SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo

MONDAY, Dec. 12, 2022 -- For patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS) of 11 to 25, adjuvant endocrine therapy...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news